About Cryo-Cell InternationalCryo-Cell International, Inc. is the world's first private cord blood bank to separate and store stem cells. Founded in 1989, Cryo-Cell began storing cord blood stem cells in 1992. Through its partnership with Saneron CCEL Therapeutics, it is affiliated with over 20 patents related to cord blood stem cells. More than 500,000 parents from 87 countries trust Cryo-Cell to preserve their family members' stem cells. Cryo-Cell's mission is to provide clients with state-of-the-art stem cell cryopreservation services and support the advancement of regenerative medicine. Cryo-Cell operates in a facility that is compliant with Good Manufacturing Practice and Good Tissue Practice (cGMP/cGTP), and is ISO 9001:2008 certified and accredited by the American Association of Blood Banks. Cryo-Cell is a publicly traded company, OTC: CCEL. For more information, visit www.cryo-cell.com . The Cryo-Cell International, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=16505 About Saneron CCEL Therapeutics, Inc. Saneron CCEL Therapeutics, Inc. is a biotechnology R&D company focused on neurological and cardiac cell therapy for the early intervention and treatment of several devastating or deadly diseases which lack adequate treatment options. Saneron, a University of South Florida spin-out company, is located at the Tampa Bay Technology Incubator. Saneron is committed to providing readily available, noncontroversial stem cells for cellular therapies and has patented and patent-pending technology relating to its platform technology of umbilical cord blood and Sertoli cells.
CONTACT: Christine Duffy email@example.com (813) 749-2120